Azithromycin has no benefit for patients with severe COVID-19, RECOVERY trial data suggest

The antibiotic azithromycin has no meaningful clinical benefit for patients who are hospitalised with severe COVID-19, a preliminary analysis of data from the Randomised Evaluation of COVID-19 Therapy trial has found.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research